Ninepoint Partners’s CVS Health CVS Stock Holding History

Ninepoint Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,827	Closed	-$460K	–	87
2022 Q3	$460K	Hold	4,827	–	–	0.06%	39
2022 Q2	$447K	Hold	4,827	–	–	0.06%	42
2022 Q1	$489K	Hold	4,827	–	–	0.1%	51
2021 Q4	$498K	Buy	+4,827	New	+$446K	0.15%	46
2019 Q1	–	Sell	-3,000	Closed	-$197K	–	92
2018 Q4	$197K	Hold	3,000	–	–	0.05%	67
2018 Q3	$236K	Buy	+3,000	New	+$214K	0.04%	73

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ninepoint Partners's CVS Position: Q4 2022 in Review

Ninepoint Partners sold out of CVS Health (CVS) in Q4 2022, closing a stake of 4,827 shares — an estimated $460K sold.

Ninepoint Partners first reported a position in CVS in Q3 2018 and held it in 6 quarters. The position peaked at $498K in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

Ninepoint Partners reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
Ninepoint Partners sold 4,827 CVS Health shares in Q4 2022, an estimated $460K.
Ninepoint Partners first reported a position in CVS Health in Q3 2018 and held it in 6 quarters.
Ninepoint Partners's CVS Health position peaked at $498K in Q4 2021.
2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Ninepoint Partners's 13F filing for Q4 2022, filed 1 Feb 2023.